Atrium Therapeutics (RNA) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:49:10.404Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:49:10.404Z.

Quote observation: 2026-10-06T19:45:19.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 7.935
Unrounded diluted TTM EPS · period ending 2026-06-30: -3.85

FMP input reference: 87d00981f6afc2d6fb42b8babadf75d30967326f42a5e12d4c63051d6ceded83

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

RNA PE Ratio Metrics

PE RATIO

N/A

RNA Competitors' PE Ratio

RNA

Atrium Therapeutics, Inc.

Current

Market Cap

$135.73M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OGI

Organigram Global Inc.

vs RNA

Market Cap

$136.58M

PE Ratio

2.18

TTM Avg

9.74

3Y Avg

18.49

5Y Avg

18.49

KRMD

KORU Medical Systems, Inc.

vs RNA

Market Cap

$138.03M

PE Ratio

N/A

TTM Avg

1879.79

3Y Avg

1257.96

5Y Avg

875.52

FRNM

Freenome, Inc.

vs RNA

Market Cap

$132.43M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMRX

Immuneering Corporation

vs RNA

Market Cap

$139.04M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACOG

Alpha Cognition Inc

vs RNA

Market Cap

$139.78M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFMD

LifeMD, Inc.

vs RNA

Market Cap

$131.79M

PE Ratio

N/A

TTM Avg

18.93

3Y Avg

18.93

5Y Avg

18.93

AIRS

AirSculpt Technologies, Inc.

vs RNA

Market Cap

$131.15M

PE Ratio

N/A

TTM Avg

194.70

3Y Avg

73.96

5Y Avg

73.96

HCAT

Health Catalyst, Inc.

vs RNA

Market Cap

$131.53M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STRO

Sutro Biopharma, Inc.

vs RNA

Market Cap

$140.51M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Atrium Therapeutics, Inc. (RNA)	$135.73M	N/A	N/A	N/A	N/A
Organigram Global Inc. (OGI)vs ›	$136.58M	2.18	9.74	18.49	18.49
KORU Medical Systems, Inc. (KRMD)vs ›	$138.03M	N/A	1879.79	1257.96	875.52
Freenome, Inc. (FRNM)vs ›	$132.43M	N/A	N/A	N/A	N/A
Immuneering Corporation (IMRX)vs ›	$139.04M	N/A	N/A	N/A	N/A
Alpha Cognition Inc (ACOG)vs ›	$139.78M	N/A	N/A	N/A	N/A
LifeMD, Inc. (LFMD)vs ›	$131.79M	N/A	18.93	18.93	18.93
AirSculpt Technologies, Inc. (AIRS)vs ›	$131.15M	N/A	194.70	73.96	73.96
Health Catalyst, Inc. (HCAT)vs ›	$131.53M	N/A	N/A	N/A	N/A
Sutro Biopharma, Inc. (STRO)vs ›	$140.51M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$7.93

÷

Forward EPS (Est.)

$-4.57

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

RNA PE Ratio Metrics

RNA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics